ECM
BIIB icon

ExodusPoint Capital Management’s Biogen BIIB Stock Holding History

ExodusPoint Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.9M Buy
+151,993
New +$28M 0.22% 58
2025
Q4 		– Sell
-31,931
Closed -$4.47M – 1556
2025
Q3 		$4.47M Sell
31,931
-97,560
-75% -$13.2M 0.05% 456
2025
Q2 		$16.3M Buy
129,491
+120,009
+1,266% +$15M 0.14% 138
2025
Q1 		$1.3M Buy
+9,482
New +$1.36M 0.01% 845
2024
Q4 		– Sell
-62,915
Closed -$12.2M – 1540
2024
Q3 		$12.2M Buy
62,915
+38,059
+153% +$7.96M 0.07% 205
2024
Q2 		$5.76M Buy
+24,856
New +$5.4M 0.04% 364
2023
Q4 		– Sell
-209,160
Closed -$53.8M – 1492
2023
Q3 		$53.8M Buy
209,160
+152,308
+268% +$40.7M 0.51% 29
2023
Q2 		$16.2M Sell
56,852
-47,444
-45% -$14.1M 0.13% 151
2023
Q1 		$29M Buy
104,296
+26,437
+34% +$7.32M 0.24% 60
2022
Q4 		$21.6M Buy
77,859
+27,298
+54% +$7.71M 0.31% 59
2022
Q3 		$13.5M Sell
50,561
-6,780
-12% -$1.44M 0.18% 140
2022
Q2 		$11.7M Buy
57,341
+24,791
+76% +$5.07M 0.14% 163
2022
Q1 		$6.86M Buy
32,550
+17,583
+117% +$3.82M 0.09% 294
2021
Q4 		$3.59M Buy
14,967
+1,107
+8% +$285K 0.04% 546
2021
Q3 		$3.92M Sell
13,860
-16,572
-54% -$5.43M 0.05% 481
2021
Q2 		$10.5M Buy
30,432
+27,445
+919% +$8.31M 0.12% 139
2021
Q1 		$836K Sell
2,987
-6,176
-67% -$1.67M 0.01% 1022
2020
Q4 		$2.24M Buy
9,163
+5,872
+178% +$1.51M 0.02% 500
2020
Q3 		$934K Sell
3,291
-20,365
-86% -$5.68M 0.02% 712
2020
Q2 		$6.33M Buy
+23,656
New +$7.11M 0.16% 118
2020
Q1 		– Sell
-918
Closed -$272K – 1095
2019
Q4 		$272K Sell
918
-35,919
-98% -$9.97M 0.01% 1193
2019
Q3 		$8.58M Buy
+36,837
New +$8.58M 0.3% 66

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ExodusPoint Capital Management's BIIB Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Biogen (BIIB) in Q1 2026: 151,993 shares worth $27.9M. The stake represents 0.22% of the portfolio and ranks #58 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in BIIB as recently as Q3 2025.

ExodusPoint Capital Management first reported a position in BIIB in Q3 2019 and has held it in 22 quarters since. The position peaked at $53.8M in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • ExodusPoint Capital Management held 151,993 shares of Biogen worth $27.9M as of Q1 2026.
  • Biogen was a new ExodusPoint Capital Management position in Q1 2026.
  • Biogen made up 0.22% of ExodusPoint Capital Management's portfolio in Q1 2026, its #58 holding.
  • ExodusPoint Capital Management first reported a position in Biogen in Q3 2019 and has held it in 22 quarters since.
  • ExodusPoint Capital Management's Biogen position peaked at $53.8M in Q3 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.